OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel drug therapies for atrial fibrillation
Felix Wiedmann, Constanze Schmidt
Nature Reviews Cardiology (2024) Vol. 21, Iss. 5, pp. 275-276
Closed Access | Times Cited: 5
Felix Wiedmann, Constanze Schmidt
Nature Reviews Cardiology (2024) Vol. 21, Iss. 5, pp. 275-276
Closed Access | Times Cited: 5
Showing 5 citing articles:
Rational Design, Synthesis, and Evaluation of Novel Polypharmacological Compounds Targeting NaV1.5, KV1.5, and K2P Channels for Atrial Fibrillation
Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, et al.
Journal of Biological Chemistry (2025), pp. 108387-108387
Open Access
Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, et al.
Journal of Biological Chemistry (2025), pp. 108387-108387
Open Access
Precision medicine in the management of cardiac arrhythmias
Felix Wiedmann, Constanze Schmidt
Herz (2025)
Closed Access
Felix Wiedmann, Constanze Schmidt
Herz (2025)
Closed Access
Disease mechanism and novel drug therapies for atrial fibrillation
Constanze Schmidt, Felix Wiedmann
Medizinische Genetik (2025) Vol. 37, Iss. 2, pp. 147-154
Closed Access
Constanze Schmidt, Felix Wiedmann
Medizinische Genetik (2025) Vol. 37, Iss. 2, pp. 147-154
Closed Access
Challenges and Opportunities for Atrial Fibrillation Management
Minsi Cai, Jordi Heijman
Cardiology Discovery (2025)
Open Access
Minsi Cai, Jordi Heijman
Cardiology Discovery (2025)
Open Access
Polypharmacological Modulation of Atrial Fibrillation: Rational Design, Synthesis, and Evaluation of Novel Compounds Targeting NaV1.5, KV1.5, and K2P Channels
Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, et al.
(2024)
Open Access | Times Cited: 1
Lorena Camargo-Ayala, Mauricio Bedoya, Albert Dasí, et al.
(2024)
Open Access | Times Cited: 1
Antiarrhythmika werden zukünftig keine Bedeutung in der Therapie des Vorhofflimmerns mehr haben
Andreas Metzner, Constanze Schmidt
Herzschrittmachertherapie + Elektrophysiologie (2024) Vol. 35, Iss. 4, pp. 274-281
Closed Access
Andreas Metzner, Constanze Schmidt
Herzschrittmachertherapie + Elektrophysiologie (2024) Vol. 35, Iss. 4, pp. 274-281
Closed Access
Combined inhibition of atrial‐specific potassium currents as a possible anti‐arrhythmic drug therapy: A match made in silico
Vladimír Sobota
The Journal of Physiology (2024)
Open Access
Vladimír Sobota
The Journal of Physiology (2024)
Open Access
